Αlpha Beta (α/β) T cell Depleted Second HCT Is Effective for Impending Secondary Graft Failure after Reduced Intensity and Nonmyeloablative MSD HCT in Sickle Cell Disease

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Mamatha Mandava, Kelly Lyons Snelling, Hari Shankaran, David A. Jacobsohn, Robert Sheppard Nickel, Anant Vatsayan

DOI: 10.1016/j.jtct.2025.12.275

Cited by: 2

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Hemoglobinopathies and Related Disorders Acute Myeloid Leukemia Research